The ACEF II Risk Score for cardiac surgery: updated but still parsimonious

医学 射血分数 内科学 心脏病学 逻辑回归 心肌梗塞 外科 心力衰竭
作者
Marco Ranucci,Valeria Pistuddi,Sabino Scolletta,Carlo De Vincentiis,Lorenzo Menicanti
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:39 (23): 2183-2189 被引量:39
标识
DOI:10.1093/eurheartj/ehx228
摘要

The age, creatinine, and ejection fraction (ACEF) score was introduced in 2009 and is presently included in the guidelines for myocardial revascularization of the European Society of Cardiology and Association for Cardio-Thoracic Surgery as a risk stratification tool for surgical and percutaneous myocardial revascularization. The present study introduces an updated version of the ACEF (ACEF II) inclusive of emergency surgery and pre-operative anaemia.The development series includes 7011 consecutive cardiac surgery patients operated at a single institution. The validation series includes 1687 consecutive cardiac surgery patients operated in a different institution. The five factors included in the ACEF II were assessed in a multivariable logistic regression model testing their independent role as predictors of operative (in hospital or 30 days after surgery) mortality. Based on the odds ratio of each predictor, the ACEF II score is calculated as age(years)/ejection fraction (%). Additional points are attributed to a serum creatinine level > 2 mg/dL (2 points), emergency surgery (3 points) and anaemia [haematocrit (HCT) < 36%, 0.2 points per each HCT point below 36%]. The final model was well calibrated. Discrimination of the ACEF II (c-statistics 0.814) was significantly (P = 0.041) better than the ACEF (c-statistics 0.773) and equal to the EuroSCORE II. In the external validation, the ACEF II confirmed a better discrimination than the ACEF and good calibration properties.The ACEF II allows the inclusion of emergency patients and, through a re-modulation of the coefficients and the inclusion of anaemia, appears more adequate to the present cardiac surgery scenario.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
香蕉觅云应助机灵的丹雪采纳,获得10
1秒前
我是你爷爷完成签到,获得积分20
1秒前
小马甲应助昏睡的妙梦采纳,获得30
2秒前
Hana完成签到,获得积分20
2秒前
Lucas应助www采纳,获得10
2秒前
今后应助0000采纳,获得10
4秒前
5秒前
5秒前
Yangxiaohui完成签到 ,获得积分10
6秒前
yingtiao完成签到 ,获得积分10
6秒前
8秒前
Search瞬间发布了新的文献求助10
11秒前
14秒前
15秒前
15秒前
15秒前
善学以致用应助DIDIDI采纳,获得10
16秒前
布丁拿铁发布了新的文献求助10
16秒前
pluto应助vastom采纳,获得10
16秒前
英姑应助MGQQbg采纳,获得50
16秒前
哲学带带师完成签到,获得积分10
17秒前
17秒前
asdfzxcv应助cw采纳,获得10
17秒前
hx完成签到 ,获得积分10
17秒前
英姑应助memory采纳,获得10
18秒前
Hana发布了新的文献求助20
18秒前
18秒前
Miao发布了新的文献求助10
19秒前
20秒前
仲滋滋发布了新的文献求助10
24秒前
研友_VZG7GZ应助KasenDen采纳,获得10
25秒前
Ding-Ding完成签到,获得积分10
26秒前
26秒前
彭洪凯完成签到,获得积分10
28秒前
徐徐完成签到 ,获得积分10
28秒前
hzw完成签到,获得积分10
31秒前
望舒完成签到,获得积分10
32秒前
32秒前
wsuser完成签到,获得积分10
33秒前
Orange应助zzg采纳,获得10
35秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Les Mantodea de guyane 2500
VASCULITIS(血管炎)Rheumatic Disease Clinics (Clinics Review Articles) —— 《风湿病临床》(临床综述文章) 1000
Feldspar inclusion dating of ceramics and burnt stones 1000
What is the Future of Psychotherapy in a Digital Age? 801
The Psychological Quest for Meaning 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5971903
求助须知:如何正确求助?哪些是违规求助? 7290045
关于积分的说明 15993025
捐赠科研通 5109810
什么是DOI,文献DOI怎么找? 2744103
邀请新用户注册赠送积分活动 1709926
关于科研通互助平台的介绍 1621839